Literature DB >> 17473382

Two insulin gene single nucleotide polymorphisms associated with type 1 diabetes risk in the Finnish and Swedish populations.

Antti-Pekka Laine1, Hanna Holmberg, Anita Nilsson, Eva Ortqvist, Minna Kiviniemi, Outi Vaarala, Hans K Akerblom, Olli Simell, Mikael Knip, Johnny Ludvigsson, Sten-A Ivarsson, Karin Larsson, Ake Lernmark, Jorma Ilonen.   

Abstract

We have developed high-throughput tests for the detection of the insulin gene region SNPs -23HphI and -2221MspI. The potential of these markers to enhance the efficiency of type 1 diabetes risk screening was then evaluated by analyzing them in Finnish and Swedish populations. Blood spots on filter paper were analyzed using PCR followed by sequence-specific hybridization and time-resolved fluorometry reading. Distribution of the genotypes at both positions differed significantly among the affected children compared to the controls. The risk genotypes (CC, AA) were significantly more common in Finland than in Sweden, both among patients and controls. The VNTR genotype homozygous for the protective class III alleles showed a significantly stronger protective effect than the heterozygote (p=0.02). Analyzing both SNPs enabled the detection of VNTR class III subclasses IIIA and IIIB. The observed significance between effects of the protective genotypes was due to the strong protective effect of the IIIA/IIIA genotype. IIIA/IIIA was the only genotype with significant discrepancy between protective effects compared to the other class III genotypes. These observations suggest that heterogeneity between the protective IDDM2 lineages could exist, and analyzing both -23HphI and -2221MspI would thus potentially enhance the sensitivity and specificity of type 1 diabetes risk estimation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473382      PMCID: PMC3850817          DOI: 10.1155/2007/574363

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  6 in total

1.  Expansion of CD4+CD25+FOXP3+ regulatory T cells in infants of mothers with type 1 diabetes.

Authors:  Kristiina Luopajärvi; Janne K Nieminen; Jorma Ilonen; Hans K Akerblom; Mikael Knip; Outi Vaarala
Journal:  Pediatr Diabetes       Date:  2012-02-15       Impact factor: 4.866

2.  Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.

Authors:  Rocky Strollo; Chiara Vinci; Y K Stella Man; Sara Bruzzaniti; Erica Piemonte; Ghadeer Alhamar; Silvia Irina Briganti; Ilaria Malandrucco; Flavia Tramontana; Chiara Fanali; James Garnett; Roberto Buccafusca; Perrin Guyer; Mark Mamula; Eddie A James; Paolo Pozzilli; Johnny Ludvigsson; Paul G Winyard; Mario Galgani; Ahuva Nissim
Journal:  Diabetologia       Date:  2022-10-07       Impact factor: 10.460

3.  Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of β-cell autoimmunity.

Authors:  Johanna Lempainen; Robert Hermann; Riitta Veijola; Olli Simell; Mikael Knip; Jorma Ilonen
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

4.  Patterns of β-cell autoantibody appearance and genetic associations during the first years of life.

Authors:  Jorma Ilonen; Anna Hammais; Antti-Pekka Laine; Johanna Lempainen; Outi Vaarala; Riitta Veijola; Olli Simell; Mikael Knip
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

Review 5.  Early prediction of autoimmune (type 1) diabetes.

Authors:  Simon E Regnell; Åke Lernmark
Journal:  Diabetologia       Date:  2017-05-26       Impact factor: 10.122

6.  Etiopathogenesis of insulin autoimmunity.

Authors:  Norio Kanatsuna; George K Papadopoulos; Antonis K Moustakas; Ake Lenmark
Journal:  Anat Res Int       Date:  2012-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.